OVID CIK: 1636651

Ovid Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
119
FY22:
−55.2
FY23:
−45.8
FY24:
−56.0
FY25:
−38.3
Change from FY21 to FY25
millions USD
FY21:
−1.82
FY22:
−87.9
FY23:
−2.58
FY24:
54.6
FY25:
−49.9
Change from FY21 to FY25
millions USD
FY21:
0.90
FY22:
0.18
FY23:
30.5
FY24:
0.62
FY25:
75.2
millions USD
FY21:
118
FY22:
−143
FY23:
–
FY24:
−0.74
FY25:
−13.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
118
FY22:
−56.5
FY23:
−45.8
FY24:
−56.0
FY25:
−38.3

All amounts in millions USD Data source:SEC EDGAR